Digital Transformation “CHUGAI DIGITAL”｜About Chugai

UPDATES

Jun 01, 2023: Chugai Selected as “DX Platinum Companies 2023-2025” in Digital Transformation Stocks (DX Stocks) 2023
Jun 08, 2022: Chugai Receives DX Grand Prix 2022 Awards in Digital Transformation Stocks (DX Stocks) 2022

VISION

Chugai has set forth “CHUGAI DIGITAL VISION 2030” with a view to 2030.

STRATEGY

To realize “CHUGAI DIGITAL VISION 2030,” three basic strategies will transform Chugai’s business and provide healthcare solutions that change society:

1 Strengthen the digital platform

We aim to establish a global-level IT infrastructure by integrating various internal data and constructing an analysis platform. In addition, we will actively promote the recruitment and development of digital talent and establish a system that allows employees to freely express their ideas and challenges, thereby establishing a foundation for new value creation.

2 Optimize all value chains

We will use digital technology to dramatically boost the efficiency of each department and function, in particular production and marketing processes. Through a comprehensive analysis of customer data, we will also contribute to the development of new solutions to enhance customer experience.

3 Digital transformation for drug discovery and development (DxD3^*)

Based on these three initiatives, we aim to realize next-generation personalized healthcare that only Chugai can provide.

*DxD3…Digital transformation for Drug Discovery and Development

AI-leveraging drug discovery

By utilizing AI technologies such as machine learning and deep learning, we will improve the probability of success in drug development. We will realize a significant reduction in time and cost through automation and streamlining of the drug discovery process, to innovate and improve the efficiency of the entire process.

Digital biomarkers (dBM) initiatives

By collecting and analyzing physiological data using wearable devices, we will work to create new indicators through digital technologies, such as visualization of patients’ conditions and prediction of disease onset, to provide new values to patients.

Utilization of real-world data (RWD)

Utilizing real-world data (RWD) and other big data in a timely and appropriate manner, will help us understand the condition of patients in actual clinical practice, which could not be learned by clinical trials alone. This will enable us to provide healthcare services that quickly offer optimal treatment for each patient.

PEOPLE

Teams

In October 2019, Chugai established “Digital Strategy Department” to lead company-wide DX. Business and IT specialists are working together to create new values in the healthcare field, while respecting individual skills and free ideas.

Working at Chugai

“I work with a variety of data, including genomic data, pathological images, and digital biomarkers. My wish is to support data scientists on the front line.”

Digital Solution Architect, Digital Strategy Department

“I can validate the models I design in our in-house laboratory. A wide variety of unique data that can only be found here in the world is generated daily from our laboratory.”

Data Scientist, Discovery Technology Department, Research Division

“I believe that we can give back and contribute to the society by analyzing healthcare data.”

Data Scientist, Biometrics Department, Clinical Development Division

DISCUSSION: Digital transformation for drug discovery and development

Yoshito Nakanishi, Ph.D., Head of Digital Strategy Dept.
Tsunoda Hiroyuki, Ph.D., Head of Discovery Technology Dept., Research Div.
Toru Maruyama, Ph.D., Discovery Technology Dept., Research Div.